What low ferritin, low transferrin saturation, and anemia criteria qualify a patient for intravenous iron therapy?

Ferritin and Laboratory Parameters for Intravenous Iron Therapy

Intravenous iron therapy should be administered when transferrin saturation (TSAT) is <20%, regardless of ferritin level, as this is the most reliable indicator of iron deficiency that predicts clinical benefit from IV iron. 1

Key Laboratory Thresholds

Primary Criterion: Transferrin Saturation

• TSAT <20% is the single most important parameter for identifying patients who will benefit from IV iron therapy
• This threshold has high sensitivity for diagnosing both absolute and functional iron deficiency 2
• Recent meta-analysis data from heart failure trials demonstrates that patients with TSAT <20% show significant reduction in cardiovascular death and heart failure hospitalizations (RR 0.81), while those with TSAT ≥20% show no benefit (RR 0.98) 1

Ferritin Thresholds (Context-Dependent)

Without inflammation:

• Ferritin <15 μg/L: Highly specific for iron deficiency (specificity 0.99) 3
• Ferritin <30 μg/L: Generally indicates low body iron stores 3
• Ferritin <45 μg/L: Optimal trade-off between sensitivity and specificity (specificity 0.92) 3, 4
• Goal ferritin after treatment: ≥50 ng/mL 2

With inflammation or chronic disease:

• Ferritin <100 ng/mL is diagnostic of iron deficiency 4
• Ferritin >150 μg/L makes absolute iron deficiency unlikely, even with inflammation 3

Combined Criteria for Heart Failure

The American and European guidelines define iron deficiency in heart failure as:

• Ferritin <100 ng/mL, OR
• Ferritin 100-299 ng/mL AND TSAT <20% 5

However, the most recent evidence suggests TSAT <20% alone is sufficient to identify patients who benefit from IV iron, regardless of ferritin level 1

Anemia Thresholds

While specific hemoglobin cutoffs vary by guideline:

• WHO defines anemia as Hb <130 g/L in men, <120 g/L in non-pregnant women 3
• More severe anemia (Hb <110 g/L in men, <100 g/L in non-menstruating women) warrants urgent investigation 3
• Important caveat: Iron deficiency can exist without anemia (non-anemic iron deficiency), and treatment may still be indicated based on symptoms 3

Critical Clinical Considerations

When Ferritin is Misleading

Ferritin is an acute phase reactant and can be falsely elevated in:

• Inflammatory conditions
• Chronic disease states
• Infection
• Malignancy

In these situations, rely primarily on TSAT <20% to diagnose functional iron deficiency 2, 3

Timing of Laboratory Assessment

• Do not check iron parameters within 4 weeks of IV iron administration - circulating iron interferes with assays and produces spurious results 2
• Optimal timing: 4-8 weeks after last infusion 2
• Hemoglobin should increase by 1-2 g/dL within 4-8 weeks of therapy 2

Discordant Results

When ferritin is elevated but TSAT is low:

• This indicates functional iron deficiency - iron stores exist but are not bioavailable for erythropoiesis
• Treat based on TSAT <20% in this scenario 2
• Consider soluble transferrin receptor (sTfR) if available, though turnaround time is often prolonged 2

Practical Algorithm

1. Measure TSAT and ferritin simultaneously
2. If TSAT <20%: Patient qualifies for IV iron, proceed with treatment
3. If TSAT ≥20% but ferritin <45 ng/mL (no inflammation): Consider oral iron first
4. If inflammation present: Use ferritin <100 ng/mL threshold, but prioritize TSAT <20%
5. Reassess at 4-8 weeks post-treatment, not sooner

The evidence strongly supports using TSAT <20% as the primary qualifying parameter for IV iron therapy, as it best predicts clinical benefit and is less affected by inflammatory confounders than ferritin alone.